Aurobindo Pharma receives USFDA’s nod for Azithromycin Oral Suspension
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Azithromycin Oral Suspension 100 mg /5 mL and 200 mg/5 mL. Azithromycin oral suspension, a generic version of Pfizer Inc’s Zithromax oral suspension. The product will be launched in November 2018. Azithromycin oral suspension is indicated for … Read more